Scott Wallask, BA

Scott Wallask is senior editorial manager at Today’s Clinical Labs and its sibling brands, The Dark Report, G2 Intelligence, Lab Manager, and Lab Design News. During his 30-year career, he has covered the clinical lab, healthcare, and high-tech markets during stints at TechTarget, HCPro, ZoomInfo, and the SAPinsider family of online publications. A former newspaper reporter, he graduated from Northeastern University with a bachelor’s degree in journalism.

Home
Author
Scott Wallask, BA

Articles by Scott Wallask, BA

Proscia's Aperture allows clinical labs to share data for drug discovery

With Release of Aperture, Proscia Brings Clinical Labs Closer to Drug Discovery

Scott Wallask, BA

AI analysis of pathology results could result in new revenue streams for laboratories

This year at ADLM, IVD manufacturers and software vendors expressed interest in fighting AMR with medical labs by raising more awareness with consumers about the risks involved.

Vendors and Clinicians Promote Fighting AMR Through Greater Public Awareness

Scott Wallask, BA

Once again, clinical labs are at the forefront of a public health battle, this time against antimicrobial resistance

Clinical lab decision-makers must consider rival factors for technology purchases, according to Proscia survey results.

Proscia Survey Results Indicate Strong Competing Factors Behind Lab Tech Purchases

Scott Wallask, BA

Functionality, user experience, and pricing vie for the attention of clinical laboratory buyers

The dismissal of CLIAC leaves a vacuum where medical lab science discussion can no longer take place, ADLM’s president says.

‘CLIAC Served as a Critical Venue’ for Lab Community, Says ADLM President

Scott Wallask, BA

Anthony Killeen reacts to news that influential committee has been dismantled by the US federal government

At the 2025 Lab Manager Leadership Summit, Octavia Peck Palmer discussed community medical needs.

Communication Strategies Prove Popular at Lab Manager Leadership Summit

Scott Wallask, BA

The need for clinical lab managers to communicate effectively ran the gamut from testing information to hiring and compliance

With BD selling its diagnostics and life sciences business, clinical labs may see a new player could emerge in the IVD market.

What BD Selling Its Diagnostics Business Could Mean for Clinical Labs

Scott Wallask, BA

Becton Dickinson’s plans will shift the IVD market and possibly create a stronger contender

Photo of a clinical laboratory professional pointing to a digital pathology slide. Digital pathology adoption challenges continue for clinical labs, according to Labcorp.

Slow Digital Pathology Adoption Continues, According to Labcorp Report

Scott Wallask, BA

Chief Medical Officer Deborah Sesok-Pizzini discusses digital pathology challenges and opportunities

A TV screen advises viewers to “please stand by.” The Trump administration’s pause in federal health communications is being watched by clinical lab workers.

Pause in Federal Health Communications Should Concern Clinical Lab Workers

Scott Wallask, BA

Clinical lab veterans and newcomers have reason to monitor the shutdown of information from the Trump administration

Image of Six Sigma on a keyboard button. Six Sigma in clinical labs offers a way to improve quality control practices.

Six Sigma in Clinical Labs: Data Leads to Changes in Quality Control

Scott Wallask, BA

Saint Peter’s Healthcare System took advantage of metrics provided by its IVD partner to improve the way it monitors test performance

Image of the US White House. Clinical labs are wondering how incoming President Donald Trump might influence LDT changes.

Will President-Elect Donald Trump Change the FDA’s LDT Final Rule?

Scott Wallask, BA

Clinical labs eager for relief from upcoming FDA compliance dates are looking to the new presidential administration

: Image of Congress with a backdrop of a hundred-dollar bill. PAMA cuts to clinical lab services were avoided by a recent vote in Congress.

PAMA Cuts Averted Again for Clinical Lab Services

Scott Wallask, BA

ACLA applauds congressional action to delay Medicare decreases and urges long-term reform

Image of Tosoh Bioscience’s G8 analyzer, one option for medical labs in the clinical chemistry analyzer market.

Clinical Chemistry Analyzer Market on the Rise: What’s Driving Demand?

Scott Wallask, BA

To capture new demand, clinical labs should note advancing technology and rising disease mortality

Photo taken of the front of the U.S. Supreme Court showing stairs and large columns.

Future of FDA’s LDT Rule Uncertain with Latest Supreme Court Decision

Scott Wallask, BA

In overturning the Chevron case, justices diminish the power of federal agencies like the FDA

Judge’s gavel on legal reference books

ACLA Sues the FDA Over Final Rule to Regulate Laboratory-Developed Tests as Medical Devices

Scott Wallask, BA

‘FDA’s final rule is the wrong approach’ for LDTs, ACLA president says

Participants at conference raise arms upward

Tips to Improve Lab Advocacy and Employee Engagement

Scott Wallask, BA

These two goals were prominent themes during the Lab Manager Leadership Summit’s Clinical Track